Literature DB >> 10956318

Modulation of the renin-angiotensin system and retinopathy.

N Chaturvedi1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2000        PMID： 10956318      PMCID： PMC1766540          DOI： 10.1136/heart.84.suppl_1.i29

Source DB:  PubMed          Journal:  Heart        ISSN： 1355-6037            Impact factor:   5.994


× No keyword cloud information.
  5 in total

1.  Captopril inhibits angiogenesis and slows the growth of experimental tumors in rats.

Authors:  O V Volpert; W F Ward; M W Lingen; L Chesler; D B Solt; M D Johnson; A Molteni; P J Polverini; N P Bouck
Journal:  J Clin Invest       Date:  1996-08-01       Impact factor: 14.808

2.  Losartan reduces albuminuria in patients with essential hypertension. An enalapril controlled 3 months study.

Authors:  S Nielsen; J Dollerup; B Nielsen; H A Jensen; C E Mogensen
Journal:  Nephrol Dial Transplant       Date:  1997       Impact factor: 5.992

3.  Captopril inhibits the 72 kDa and 92 kDa matrix metalloproteinases.

Authors:  D Sorbi; M Fadly; R Hicks; S Alexander; L Arbeit
Journal:  Kidney Int       Date:  1993-12       Impact factor: 10.612

4.  Increased plasma metalloproteinase-9 concentrations precede development of microalbuminuria in non-insulin-dependent diabetes mellitus.

Authors:  I Ebihara; T Nakamura; N Shimada; H Koide
Journal:  Am J Kidney Dis       Date:  1998-10       Impact factor: 8.860

5.  Effect of antihypertensive treatment on blood-retinal barrier permeability to fluorescein in hypertensive type 1 (insulin-dependent) diabetic patients with background retinopathy.

Authors:  H H Parving; M Larsen; E Hommel; H Lund-Andersen
Journal:  Diabetologia       Date:  1989-07       Impact factor: 10.122
  5 in total
  9 in total

1.  Blood pressure control and diabetic retinopathy.

Authors:  R Klein; B E K Klein
Journal:  Br J Ophthalmol       Date:  2002-04       Impact factor: 4.638

2.  Management of type 2 diabetes: NICE guidelines.

Authors:  Latika Sibal; Philip D Home
Journal:  Clin Med (Lond)       Date:  2009-08       Impact factor: 2.659

3.  Relationship of blood pressure to retinal vessel diameter in type 1 diabetes mellitus.

Authors:  Ronald Klein; Chelsea E Myers; Barbara E K Klein; Bernard Zinman; Robert Gardiner; Samy Suissa; Alan R Sinaiko; Sandra M Donnelly; Paul Goodyer; Trudy Strand; Michael Mauer
Journal:  Arch Ophthalmol       Date:  2010-02

4.  The predictive role of markers of Inflammation and endothelial dysfunction on the course of diabetic retinopathy in type 1 diabetes.

Authors:  Hussein A Rajab; Nathaniel L Baker; Kelly J Hunt; Richard Klein; Patricia A Cleary; John Lachin; Gabriel Virella; Maria F Lopes-Virella
Journal:  J Diabetes Complications       Date:  2014-08-20       Impact factor: 2.852

Review 5.  Retinal ganglion cells in diabetes.

Authors:  Timothy S Kern; Alistair J Barber
Journal:  J Physiol       Date:  2008-06-19       Impact factor: 5.182

6.  Circulating vascular endothelial growth factor (VEGF) levels in advanced stage cancer patients compared to normal controls and diabetes mellitus patients with critical ischemia.

Authors:  Yoka H Kusumanto; Coby Meijer; Wendy Dam; Nanno H Mulder; Geke A P Hospers
Journal:  Drug Target Insights       Date:  2007-05-18

7.  High concentrations of AGE-LDL and oxidized LDL in circulating immune complexes are associated with progression of retinopathy in type 1 diabetes.

Authors:  Maria F Lopes-Virella; Nathaniel L Baker; Kelly J Hunt; Timothy J Lyons; Alicia J Jenkins; Gabriel Virella
Journal:  Diabetes Care       Date:  2012-04-17       Impact factor: 19.112

8.  Dual blockade of Renin Angiotensin system in reducing the early changes of diabetic retinopathy and nephropathy in a diabetic rat model.

Authors:  Pugazhenthan Thangaraju; Amitava Chakrabarti; Dibyajyoti Banerjee; Debasish Hota; Alka Bhatia; Amod Gupta
Journal:  N Am J Med Sci       Date:  2014-12

Review 9.  Therapeutic targets of renin-angiotensin system in ocular disorders.

Authors:  Rajesh Choudhary; Mandeep Singh Kapoor; Amrita Singh; Surendra H Bodakhe
Journal:  J Curr Ophthalmol       Date:  2016-10-20
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.